CLINICAL STUDIES OF MEROPENEM IN UROLOGY
Meropenem (MEPM) was administered to 16 patients with chronic complicated urinary tract infection (UTI) at a dose of 0.5-1g b. i. d. for 5 days, and its clinical efficacy and safety were evaluated. 1) Clinical efficacy was evaluated according to the criteria of the Japanese UTI Committee. The clinic...
Saved in:
| Published in: | CHEMOTHERAPY Vol. 40; no. Supplement1; pp. 926 - 930 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English Japanese |
| Published: |
Japanese Society of Chemotherapy
1992
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Meropenem (MEPM) was administered to 16 patients with chronic complicated urinary tract infection (UTI) at a dose of 0.5-1g b. i. d. for 5 days, and its clinical efficacy and safety were evaluated. 1) Clinical efficacy was evaluated according to the criteria of the Japanese UTI Committee. The clinical response in 16 patients with chronic complicated UTI was moderate in 10 and poor in 6, the overall efficacy rate being 63%. Bacteriologically, 21 (88%) of 24 strains were eradicated. 2) Eruption was observed in two patients. No abnormal changes in laboratory examinations were observed. 3) From the above results, we consider that MEPM is a useful and safe antibiotic for chronic complicated UTI. |
|---|---|
| ISSN: | 0009-3165 1884-5894 |
| DOI: | 10.11250/chemotherapy1953.40.Supplement1_926 |